Quick Answer
AVAI BIO, INC. reported Stockholders Equity of -$1.56 million for the year ending 2025.
- AVAI BIO, INC. showed a decrease of -6.6% in Stockholders Equity from 2024 to 2025.
- This data is from AVAI BIO, INC.'s annual report (Form 10-K), filed with the SEC on July 8, 2025.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: -$2.9 thousand | Q3 2018: -$1.8 thousand | Q4 2018: -$20.8 thousand | Q2 2019: -$91.5 thousand | Q3 2019: -$122.5 thousand | Q4 2019: -$132.7 thousand | Q1 2020: -$37.7 thousand | Q2 2020: $13.4 thousand | Q3 2020: $73.2 thousand | Q4 2020: -$334.1 thousand | Q1 2021: -$327.4 thousand | Q2 2021: $67.3 thousand | Q3 2021: -$66.0 thousand | Q4 2021: -$416.9 thousand | Q2 2022: -$440.0 thousand | Q3 2022: -$419.8 thousand | Q4 2022: -$539.5 thousand | Q1 2023: -$633.3 thousand | Q2 2023: -$993.8 thousand | Q3 2023: -$991.3 thousand | Q4 2023: -$1.40 million | Q1 2024: -$1.47 million | Q2 2024: -$2.08 million | Q3 2024: -$1.82 million | Q4 2024: -$2.14 million | Q1 2025: -$1.56 million | Q2 2025: -$1.99 million | Q3 2025: -$2.30 million | Q4 2025: -$2.79 million.
- Historical annual values: Fiscal year 2025: -$1.56 million | Fiscal year 2024: -$1.47 million | Fiscal year 2023: -$633.3 thousand | Fiscal year 2022: -$405.6 thousand | Fiscal year 2021: -$327.4 thousand | Fiscal year 2020: -$37.7 thousand | Fiscal year 2020: -$37.7 thousand | Fiscal year 2019: -$49.6 thousand | Fiscal year 2018: $3.3 thousand | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: